Diabetic Retinopathy Market

The global Diabetic Retinopathy Market is reported to reach a valuation of USD 9,830 million in 2025 to USD 18,259.3 million by 2035. Demand for Diabetic Retinopathy is expected to rise at a CAGR of 5.8% over the forecast period.  Non-proliferative diabetic retinopathy is expected to hold a 65.0% share in 2025, which is attributed to higher prevalence of NPDR in diabetic patients. Anti-VEGF Drugs will dominate the application segment with a 61.2% market share, owing to to the proven efficacy of anti-VEGF treatments in managing diabetic macular edema (DME) and other advanced stages of diabetic retinopathy.